Danaher Corporation (DHR) — Stock Price, Chart & Analysis
Danaher Corporation (DHR) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $155.42B and a trailing P/E ratio of 39.41. Over the past 52 weeks, DHR has traded between $160.93 and $242.80. Danaher Corporation pays a dividend yielding 0.7%. View the live DHR chart, technical opinion, analyst ratings, fundamentals and latest news below.
Danaher Corporation (DHR) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $155.42B |
| P/E ratio (TTM) | 39.41 |
| EPS (TTM) | $5.61 |
| Dividend yield | 0.7% |
| 52-week high | $242.80 |
| 52-week low | $160.93 |
| Beta | 0.81 |
| Avg. volume | 4.72M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Frequently asked questions about Danaher Corporation (DHR)
How much does one share of Danaher Corporation cost?
As of the latest update, one share of Danaher Corporation (DHR) trades at $100 (+0.00% today).
What is Danaher Corporation's market cap?
Danaher Corporation has a market capitalization of approximately $155.42B.
What is Danaher Corporation's P/E ratio?
Danaher Corporation has a trailing price-to-earnings (P/E) ratio of 39.41.
What is Danaher Corporation's earnings per share (EPS)?
Danaher Corporation's trailing twelve-month EPS is $5.61.
Does Danaher Corporation pay a dividend?
Yes — Danaher Corporation pays a dividend with a yield of 0.7% ($1.60 per share annually).
What is Danaher Corporation's 52-week trading range?
Over the past year, DHR has traded between $160.93 and $242.80.
What is the analyst price target for Danaher Corporation?
The mean analyst price target for Danaher Corporation is $230.83. This is informational only and not investment advice.
Latest Danaher Corporation (DHR) news
- Global Pharmaceutical Filtration Report: Biologics Manufacturing Shifts as Danaher, Merck KGaA, Sartorius, 3M and Thermo Fisher Reshape the MarketNews · Sep 23, 2026
- Bioreactors Market Outlook 2026-2035 - Featuring Profiles of 3 Leading Companies: Sartorius, Thermo Fisher Scientific, and DanaherNews · Sep 23, 2026
- Danaher Schedules Third Quarter 2026 Earnings Conference CallNews · Sep 22, 2026
- Capitalize on the Label-Free Detection Market Shift: Track How Danaher, Sartorius, Agilent, Bruker and Revvity Are Disrupting R&D ROI and Reshaping Global Revenue Through 2030News · Sep 22, 2026
- Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did BetterNews · Sep 18, 2026
- 2 Unpopular Stocks That Should Get More Attention and 1 We QuestionNews · Sep 18, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live DHR dashboard…